5-[(1R)-1-(2,7-diazaspiro[3.5]nonan-2-yl)-2,3-dihydro-1H-inden-5-yl]pyrazine-2-carboxylic acid;dihydrochloride
C21H26Cl2N4O2 — CID 158811645
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[(1R)-1-(2,7-diazaspiro[3.5]nonan-2-yl)-2,3-dihydro-1H-inden-5-yl]pyrazine-2-carboxylic acid;dihydrochloride
5-[(1R)-1-(2,7-diazaspiro[3.5]nonan-2-yl)-2,3-dihydro-1H-inden-5-yl]pyrazine-2-carboxylic acid;dihydrochloride (PubChem CID 158811645) has the molecular formula C21H26Cl2N4O2 and a molecular weight of 437.37 g/mol. Its IUPAC name is 5-[(1R)-1-(2,7-diazaspiro[3.5]nonan-2-yl)-2,3-dihydro-1H-inden-5-yl]pyrazine-2-carboxylic acid;dihydrochloride.
Molecular Properties
| Compound Name | 5-[(1R)-1-(2,7-diazaspiro[3.5]nonan-2-yl)-2,3-dihydro-1H-inden-5-yl]pyrazine-2-carboxylic acid;dihydrochloride |
|---|---|
| PubChem CID | 158811645 |
| Molecular Formula | C21H26Cl2N4O2 |
| Molecular Weight | 437.37 g/mol |
| Exact Mass | 436.14 |
| IUPAC Name | 5-[(1R)-1-(2,7-diazaspiro[3.5]nonan-2-yl)-2,3-dihydro-1H-inden-5-yl]pyrazine-2-carboxylic acid;dihydrochloride |
| SMILES | Cl.Cl.O=C(O)c1cnc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCNCC3)C2)cn1 |
| InChI | InChI=1S/C21H24N4O2.2ClH/c26-20(27)18-11-23-17(10-24-18)15-1-3-16-14(9-15)2-4-19(16)25-12-21(13-25)5-7-22-8-6-21;;/h1,3,9-11,19,22H,2,4-8,12-13H2,(H,26,27);2*1H/t19-;;/m1../s1 |
| InChIKey | RRIMEOYQXVAIAQ-JQDLGSOUSA-N |
| XLogP | 3.36 |
| TPSA | 78.35 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 437.37 |
| LogP ≤ 5 | 3.36 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158811645 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.